|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.280 USD | +0.57% |
|
-3.12% | -64.52% |
| 07-08 | Seres Therapeutics Announces Early Clinical Data Showing Potential For SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis | CI |
| 07-08 | Seres Therapeutics, Inc. - Special Call |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 6.28 | 8.14 | 10.08 |
| Spread/Res. | -15.92% | -35.14% | -47.62% |
| Spread/Supp. | +3.33% | +3.33% | +54.84% |
| Support | 5.11 | 5.11 | 3.41 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MCRB Stock
- Charts Seres Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
